
Jae W. Lee
Examiner (ID: 7721, Phone: (571)272-9949 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656 |
| Total Applications | 1186 |
| Issued Applications | 830 |
| Pending Applications | 111 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19464498
[patent_doc_number] => 20240318167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => HUMANIZED CELL LINE
[patent_app_type] => utility
[patent_app_number] => 18/525460
[patent_app_country] => US
[patent_app_date] => 2023-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18525460
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/525460 | Humanized cell line | Nov 29, 2023 | Issued |
Array
(
[id] => 19281550
[patent_doc_number] => 20240218024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/507493
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507493
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507493 | METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION | Nov 12, 2023 | Pending |
Array
(
[id] => 19158034
[patent_doc_number] => 20240150741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity
[patent_app_type] => utility
[patent_app_number] => 18/507709
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507709
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507709 | Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity | Nov 12, 2023 | Pending |
Array
(
[id] => 19034478
[patent_doc_number] => 20240084293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION
[patent_app_type] => utility
[patent_app_number] => 18/502499
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 388
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18502499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/502499 | CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation | Nov 5, 2023 | Issued |
Array
(
[id] => 19113104
[patent_doc_number] => 20240124854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => Mutant Taq Polymerase Providing Faster Amplification
[patent_app_type] => utility
[patent_app_number] => 18/386621
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/386621 | Mutant Taq polymerase providing faster amplification | Nov 2, 2023 | Issued |
Array
(
[id] => 20634624
[patent_doc_number] => 12595494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Biological production of multi-carbon compounds from methane
[patent_app_type] => utility
[patent_app_number] => 18/379079
[patent_app_country] => US
[patent_app_date] => 2023-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27301
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379079 | Biological production of multi-carbon compounds from methane | Oct 10, 2023 | Issued |
Array
(
[id] => 19158099
[patent_doc_number] => 20240150806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 18/483386
[patent_app_country] => US
[patent_app_date] => 2023-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18483386
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/483386 | Programmed DNA-driven self-assembled RNA hydrogel | Oct 8, 2023 | Issued |
Array
(
[id] => 19300526
[patent_doc_number] => 20240229095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 18/483460
[patent_app_country] => US
[patent_app_date] => 2023-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18483460
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/483460 | PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL | Oct 8, 2023 | Abandoned |
Array
(
[id] => 19083364
[patent_doc_number] => 20240110165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/480647
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480647 | NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS | Oct 3, 2023 | Pending |
Array
(
[id] => 19142465
[patent_doc_number] => 20240141304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF AZETIDINONE
[patent_app_type] => utility
[patent_app_number] => 18/472540
[patent_app_country] => US
[patent_app_date] => 2023-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18472540
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/472540 | Ketoreductase polypeptides for the production of azetidinone | Sep 21, 2023 | Issued |
Array
(
[id] => 19049356
[patent_doc_number] => 20240091325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA
[patent_app_type] => utility
[patent_app_number] => 18/454701
[patent_app_country] => US
[patent_app_date] => 2023-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18454701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/454701 | Compositions and methods for treatment of homocystinuria | Aug 22, 2023 | Issued |
Array
(
[id] => 18903017
[patent_doc_number] => 20240018502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => NUCLEIC ACID ENCODING MODIFIED MEMBRANE TYPE SERINE PROTEASE 1 (MTSP-1) POLYPEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/450994
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450994
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450994 | Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use | Aug 15, 2023 | Issued |
Array
(
[id] => 19172800
[patent_doc_number] => 20240158774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Compositions and Methods for Treating Celiac Sprue Disease
[patent_app_type] => utility
[patent_app_number] => 18/357617
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357617
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357617 | Compositions and Methods for Treating Celiac Sprue Disease | Jul 23, 2023 | Abandoned |
Array
(
[id] => 19651558
[patent_doc_number] => 12173329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Acyl-ACP reductase with improved properties
[patent_app_type] => utility
[patent_app_number] => 18/355990
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 30508
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355990
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355990 | Acyl-ACP reductase with improved properties | Jul 19, 2023 | Issued |
Array
(
[id] => 19909260
[patent_doc_number] => 12285446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Compositions and methods for improving mitochondrial function
[patent_app_type] => utility
[patent_app_number] => 18/351198
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 84
[patent_no_of_words] => 28430
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351198 | Compositions and methods for improving mitochondrial function | Jul 11, 2023 | Issued |
Array
(
[id] => 20414072
[patent_doc_number] => 12497342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Methods and compositions for improving plant traits
[patent_app_type] => utility
[patent_app_number] => 18/345783
[patent_app_country] => US
[patent_app_date] => 2023-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 23345
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18345783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/345783 | Methods and compositions for improving plant traits | Jun 29, 2023 | Issued |
Array
(
[id] => 19638187
[patent_doc_number] => 12168788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => FCE mRNA capping enzyme compositions, methods and kits
[patent_app_type] => utility
[patent_app_number] => 18/340083
[patent_app_country] => US
[patent_app_date] => 2023-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11400
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18340083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/340083 | FCE mRNA capping enzyme compositions, methods and kits | Jun 22, 2023 | Issued |
Array
(
[id] => 19127508
[patent_doc_number] => 20240132861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHODS AND COMPOSITIONS FOR IN VIVO GENE EDITING BASED CELL-TYPE-SPECIFIC CELLULAR ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 18/333344
[patent_app_country] => US
[patent_app_date] => 2023-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333344
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333344 | Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering | Jun 11, 2023 | Issued |
Array
(
[id] => 19127508
[patent_doc_number] => 20240132861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHODS AND COMPOSITIONS FOR IN VIVO GENE EDITING BASED CELL-TYPE-SPECIFIC CELLULAR ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 18/333344
[patent_app_country] => US
[patent_app_date] => 2023-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333344
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/333344 | Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering | Jun 11, 2023 | Issued |
Array
(
[id] => 18831157
[patent_doc_number] => 20230399682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => COMPOSITIONS OF MATTER FOR DETECTION ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/208272
[patent_app_country] => US
[patent_app_date] => 2023-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208272
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208272 | Compositions of matter for detection assays | Jun 9, 2023 | Issued |